Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function
暂无分享,去创建一个
J. Magarian Blander | Michael Müller | Christian Trautwein | Frank Tacke | F. Tacke | C. Trautwein | J. Blander | L. Sander | R. Linke | N. Beraza | Leif E. Sander | Sara Dutton Sackett | Uta Dierssen | Naiara Beraza | Reinhold P. Linke | U. Dierssen | S. Sackett | Michael Müller
[1] M. Manns,et al. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury. , 2005, The Journal of clinical investigation.
[2] R. Medzhitov. Recognition of microorganisms and activation of the immune response , 2007, Nature.
[3] J. Raynes,et al. Serum amyloid A is an innate immune opsonin for Gram-negative bacteria. , 2006, Blood.
[4] J. Filep,et al. Prevention of In vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein. , 1997, The Journal of clinical investigation.
[5] M. Manns,et al. Interleukin-6/Glycoprotein 130-dependent Pathways Are Protective during Liver Regeneration* , 2003, The Journal of Biological Chemistry.
[6] K. Tracey,et al. Experimental Therapeutic Strategies for Severe Sepsis , 2008, Annals of the New York Academy of Sciences.
[7] Hong Tang,et al. Adaptive immune cells temper initial innate responses , 2007, Nature Medicine.
[8] J. Bylund,et al. Serum amyloid A inhibits apoptosis of human neutrophils via a P2X7‐sensitive pathway independent of formyl peptide receptor‐like 1 , 2008, Journal of leukocyte biology.
[9] R. Jove,et al. Hyperactivation of STAT3 Is Involved in Abnormal Differentiation of Dendritic Cells in Cancer , 2004, The Journal of Immunology.
[10] OLAND,et al. TREATMENT OF SEPTIC SHOCK WITH THE TUMOR NECROSIS FACTOR RECEPTOR : Fc FUSION PROTEIN C , 2000 .
[11] D. Rittirsch,et al. Immunodesign of experimental sepsis by cecal ligation and puncture , 2008, Nature Protocols.
[12] R. Hotchkiss,et al. Apoptosis and caspases regulate death and inflammation in sepsis , 2006, Nature Reviews Immunology.
[13] D. Carbone,et al. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. , 2008, Cancer cell.
[14] L. F. Kolakowski,et al. Expression and biologic characterization of the murine chemokine KC. , 1995, Journal of immunology.
[15] G. Matuschak. Lung-liver interactions in sepsis and multiple organ failure syndrome. , 1996, Clinics in chest medicine.
[16] D. Mannino,et al. Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey. , 2003, Chest.
[17] I. Kushner,et al. Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.
[18] M. Sitkovsky,et al. Model organisms: Animal Models of sepsis: setting the stage , 2005, Nature Reviews Drug Discovery.
[19] W. Nacken,et al. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein , 2008, The Journal of experimental medicine.
[20] Peter A. Ward,et al. Harmful molecular mechanisms in sepsis , 2008, Nature Reviews Immunology.
[21] B. Jenkins,et al. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice , 2002, Nature Medicine.
[22] K. Rajewsky,et al. Postnatally Induced Inactivation of gp130 in Mice Results in Neurological, Cardiac, Hematopoietic, Immunological, Hepatic, and Pulmonary Defects , 1998, The Journal of experimental medicine.
[23] E. Dupont,et al. Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients. , 1993, Gastroenterology.
[24] M. Manns,et al. Lack of gp130 expression in hepatocytes promotes liver injury. , 2003, Gastroenterology.
[25] S. Albelda,et al. Cross-Talk between Myeloid-Derived Suppressor Cells and Macrophages Subverts Tumor Immunity toward a Type 2 Response1 , 2007, The Journal of Immunology.
[26] M. Manns,et al. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. , 2008, Gastroenterology.
[27] J Ean,et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.
[28] M. Manns,et al. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. , 2008, Gastroenterology.
[29] R. Ye,et al. Cutting Edge: TLR2 Is a Functional Receptor for Acute-Phase Serum Amyloid A1 , 2008, The Journal of Immunology.
[30] G. Clermont,et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.
[31] V. Kuchroo,et al. CD11b+Ly-6Chi Suppressive Monocytes in Experimental Autoimmune Encephalomyelitis1 , 2007, The Journal of Immunology.
[32] R. Hotchkiss,et al. The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.
[33] D. Ritchie,et al. HEPATOCYTE‐STIMULATING FACTOR: A MONOCYTE‐DERIVED ACUTE‐PHASE REGULATORY PROTEIN , 1983, Annals of the New York Academy of Sciences.
[34] L. Moldawer,et al. MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsis , 2007, The Journal of experimental medicine.
[35] K. Yasukawa,et al. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. , 1993, Science.
[36] R. Badolato,et al. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes , 1994, The Journal of experimental medicine.
[37] E. Dupont,et al. Tumor necrosis factor α and interleukin 6 plasma levels in infected cirrhotic patients , 1993 .
[38] C. Trautwein,et al. Signal transducer of inflammation gp130 modulates atherosclerosis in mice and man , 2007, The Journal of experimental medicine.
[39] P. De Baetselier,et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. , 2008, Blood.
[40] K. Gupta,et al. Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer , 2007, Nature Medicine.
[41] V. Kuchroo,et al. CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. , 2007, Journal of immunology.
[42] M. Young,et al. Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors. , 1987, Cancer research.
[43] Peter A. Ward,et al. Novel strategies for the treatment of sepsis , 2003, Nature Medicine.
[44] Srinivas Nagaraj,et al. Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.
[45] S. Imbeaud,et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours , 2009, Nature.
[46] W. Alexander,et al. Defective Gp130-Mediated Signal Transducer and Activator of Transcription (Stat) Signaling Results in Degenerative Joint Disease, Gastrointestinal Ulceration, and Failure of Uterine Implantation , 2001, The Journal of experimental medicine.
[47] R. Zinkernagel,et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice , 1994, Nature.
[48] S. Opal,et al. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. , 1996, The New England journal of medicine.